Table 1 Baseline characteristics in three HCMV induced liver injury sub groups of the study. Values are given as mean ± SD or number of individuals (%). aP value of chi-square test. bP value of Kruskal–Wallis test. cP value of Dunn’s post hoc test.
Variables | HCMV IH | HCMV ICH | HCMV EHBA | P valuea | IH vs. ICHc | IH vs. EHBAc | ICH vs. EHBAc |
|---|---|---|---|---|---|---|---|
(n = 22) | (n = 39) | (n = 26) | |||||
Gender(female,%) | 5(22.7%) | 10(25.6%) | 10(38.5%) | 0.412466 | |||
GCV use,% | 12(54.5%) | 27(69.2%) | 8(30.8%) | 0.00959 | |||
P valueb | |||||||
Age,month | 3.29 ± 1.69 | 2.38 ± 0.94 | 3.29 ± 2.03 | 0.024297 | 0.017954 | 0.611361 | 0.034049 |
BMI | 17.83 ± 2.68 | 15.46 ± 2.70 | 16.33 ± 3.59 | 0.019104 | 0.014970 | 0.144924 | 0.312676 |
ALT,U/L | 142.45 ± 133.92 | 175.66 ± 145.62 | 197.45 ± 156.12 | 0.176783 | 0.241394 | 0.054314 | 0.441319 |
AST,U/L | 112.78 ± 100.91 | 246.68 ± 267.23 | 278.84 ± 150.89 | 0.000030 | 0.001060 | 0.000013 | 0.059016 |
TBIL,umol/L | 11.16 ± 7.31 | 133.66 ± 85.87 | 162.42 ± 71.43 | 6.18E-12 | 1.17E-10 | 3.26E-09 | 0.023635 |
DBIL,umol/L | 3.14 ± 2.57 | 81.37 ± 65.19 | 104.51 ± 48.10 | 2.49E-12 | 1.17E-10 | 3.26E-09 | 0.003823 |
TBA,umol/L | 23.95 ± 30.85 | 102.20 ± 85.02 | 124.02 ± 52.82 | 3.69E-09 | 8.23E-08 | 1.39E-07 | 0.027206 |
GGT,U/L | 110.54 ± 77.58 | 199.16 ± 221.16 | 363.48 ± 458.25 | 0.026581 | 0.028307 | 0.01968 | 0.252247 |
ALP,U/L | 291.59 ± 132.70 | 595.58 ± 289.98 | 514.46 ± 250.45 | 0.000002 | 3.82E-07 | 0.000344 | 0.311748 |
ALB,g/L | 37.27 ± 4.49 | 35.40 ± 5.40 | 36.98 ± 5.62 | 0.311954 | 0.326273 | 0.943610 | 0.138464 |
LDH,U/L | 335.19 ± 75.96 | 401.61 ± 120.26 | 432.04 ± 352.01 | 0.094866 | 0.021247 | 0.360049 | 0.391435 |
PT,S | 10.28 ± 0.96 | 11.89 ± 3.59 | 12.18 ± 3.29 | 0.010994 | 0.057359 | 0.002440 | 0.179165 |
WBC,109/L | 11.79 ± 6.01 | 11.92 ± 3.95 | 15.46 ± 12.34 | 0.427630 | 0.372848 | 0.220980 | 0.513357 |
NH3,umol/L | 64.58 ± 17.18 | 82.74 ± 48.21 | 76.58 ± 40.84 | 0.100737 | 0.052500 | 0.493167 | 0.132249 |